ArticleScientific reports2026
FTIR imaging identifies alterations in lung tissue structure and biochemical composition in human idiopathic pulmonary fibrosis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Doxorubicin-loaded gold nanoparticles for enhanced anticancer efficacy: in vitro, in vivo, and FTIR-based tissue analysis.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and fatal lung disease characterized by damage to the epithelial tissue and a reduced ability of the alveoli to repair themselves. This impaired repair process leads to abnormal accumulation of extracellular matrix (ECM), resulting in scarring and stiffening of lung tissue. Fourier transform infrared imaging (FTIRI) is a promising technique for imaging the biochemical changes related to fibrotic changes in a label-free and non-destructive manner, which can be analyzed to mark the progression of IPF. In this study, FTIRI was used to image human lung tissue biopsies with IPF and control biopsies without disease. In-depth spectral analyses were performed to observe the biochemical changes in the tissue composition using FTIRI. The parameters that were analyzed included collagen structure, total lipid content, lipid chain length, and phospholipids. Results showed a significant increase in lipid content in IPF compared to control, where long chain lipids dominated and phospholipids were reduced. Minor changes in collagen structure were also observed in IPF, likely attributed to the excess formation of extracellular matrix in the disease. These findings indicate that FTIRI has the potential to be a promising diagnostic technique to understand the molecular changes during IPF, as analysis of infrared data can reveal detailed biochemical information regarding disease progression and provide spatial insights on the molecular changes across the IPF lung tissue.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.